Cytodyn Inc (CYDY)

[fred198484]

You did not understand what I was saying and that is likely because I did not lay it out as clearly as I should have. I believe the FDA almost always provides a label that closely mimics the phase III tests. So, I think the for PRO 140 in combo will be for just what it says on clinicaltrials.gov. In practicality, however, since Ibalizumab will have taken almost all those MDR patients by the time PRO 140 is approved, PRO 140 may well only have as a market those patients who need yet another drug because they are also resistant to 4 or 5 classes. Thus, those patients would use both Ibalizumab and PRO 140 in combination with one other classic HIV drug if they are 4 class resistant or just those two if they are 5 class resistant. Does that make it clearer?